Christopher Paul reviews Steve Woodward’s “Ignoring the regulator's reference” with a few minor tweaks to optimize ...
Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy the ...
Abstract: Bathymetric light detection and ranging (LiDAR), which uses a laser with narrow pulsewidth and a high repetition rate, requires a real-time data acquisition system (RTDAQS) for quickly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback